跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
利血宝 - NMPA Drug Approval Details
Approvals
/
NMPA
/
Human Erythropoietin Injection
Approved
生物制品
Human Erythropoietin Injection
NICHI-IKO GIFU PLANT CO., LTD.
🇨🇳 National Medical Products Administration
Approval Date
Jan 19, 2020
Approval ID
7MaoSU5ITrF
Company
NICHI-IKO GIFU PLANT CO., LTD.
Type
生物制品
Approval Details
Approval Id
7MaoSU5ITrF
Approval Number
国药准字J20171084
Generic Name
人促红素注射液
Generic Name En
Human Erythropoietin Injection
Trade Name
利血宝
Drug Type
生物制品
Dosage Form
注射剂
Strength
10支/盒
Reg Date
2020-01-19
Company Name
NICHI-IKO GIFU PLANT CO., LTD.
Company Address
1-9-2 Otemachi, Chiyoda-ku, Tokyo, Japan
Production Company Name
NICHI-IKO GIFU PLANT CO., LTD.
Production Company Address
1040-22, Matsunoki-machi, Takayama City, Gifu, Japan
Company Detail Path
/organization/nichi-iko-gifu-plant-co-ltd
Production Company Detail Path
/organization/nichi-iko-gifu-plant-co-ltd
Approved
Quick Info
Agency
NMPA
Country
🇨🇳
Approval Date
Jan 19, 2020
Approval ID
7MaoSU5ITrF
Type
生物制品
Back to NMPA Approvals